Call our 24 hours, seven days a week helpline at 800.272.3900
Lecanemab is the second FDA-approved treatment that addresses the underlying biology of Alzheimer's and changes the course of the disease in a meaningful way for people in the early stages.
The Greater Kentucky and Southern Indiana Chapter of the Alzheimer’s Association provides service and education to 125 counties across greater Kentucky and southern Indiana. Over 5 million Americans are living with the disease and more than 90,000 of them reside in our service territory. Services provided include education programs for persons with dementia, caregivers, professionals and the general community as well as support groups and a 24/7 Helpline. Further, the Chapter advocates at the state and national level of government for research and support services on behalf of the people of Kentucky who suffer from Alzheimer's disease.
Su memoria a menudo cambia a medida que envejece. Pero la pérdida de memoria que interrumpe la vida cotidiana no es una parte típica del envejecimiento.
10 señales de advertenci
La etapa media del Alzheimer generalmente se caracteriza por ser la más larga y puede durar varios años.
Aprende más
Cómo participar
Realice el paseo
Más información